SOAGY (Sartorius AG) Other Current Liabilities : $567 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sartorius AG Other Current Liabilities?

Sartorius AG's other current liabilities for the quarter that ended in Sep. 2024 was $567 Mil.

Sartorius AG's quarterly other current liabilities increased from Mar. 2024 ($493 Mil) to Jun. 2024 ($544 Mil) and increased from Jun. 2024 ($544 Mil) to Sep. 2024 ($567 Mil).

Sartorius AG's annual other current liabilities declined from Dec. 2021 ($521 Mil) to Dec. 2022 ($447 Mil) and declined from Dec. 2022 ($447 Mil) to Dec. 2023 ($317 Mil).

Sartorius AG Other Current Liabilities Historical Data

The historical data trend for Sartorius AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Other Current Liabilities Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Sartorius AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Sartorius AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Sartorius AG Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SOAGY) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK 0NIQ:UK SRT3:Germany SRT:Germany SRT3:Germany SRT:Germany SRT3:Germany SRT:Germany SRT3:Germany SRT:Germany SRT3:Bulgaria SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.